TCN1 and hypopharynx squamous cell carcinoma: Wang et al. found that low TCN1 expression might be a potential prognostic biomarker for predicting neoadjuvant chemotherapy sensitivity and clinical outcome in local advanced hypopharyngeal squamous cell carcinoma patients [7].